Replay available

OmniAb, Inc. (OABI) Q1 2025 Earnings Call

OmniAb, Inc. (NASDAQ: OABI) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Thu, May 8, 2025 at 4:30 PMendedReplay
OmniAb, Inc. (OABI) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matt Foer

President and CEO

Bob Chen

Vice President of Discovery Systems

Puneet Sudha

Investor, Learing Partners

Replay transcript excerpt

Chief Financial Officer, and thank you all for joining our first quarter 2025 financial results conference call. There are slides to accompany today's prepared remarks, and they're available on our website at www.omniab.com. Before we begin, I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. These forward-looking statements are qualified by the cautionary statements contained in today's press release and our SEC files. Importantly, this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, today, May 8, 2025. Except as required by law, OMNIAB undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this call. Joining me on the call today is Matt Foer, OmniApp's president and CEO, and Bob Chen, our vice president of Discovery Systems. During today's call, we'll provide highlights on the company's business and operations, partner and technology updates, and our recent financial results. At the conclusion of the prepared remarks, we'll open the call to questions. And with that, let me turn the call over to Matt. Thanks, Kurt. Good afternoon, everyone, and thanks for joining us today on our call. 2025 is off to a very good start and is on track with our expectations. Despite some tumult in the broader landscape and in our industry, we're continuing to sign up new partners, and our pipeline of partnered programs continues to grow and to progress. Deal flow to start the year h...

More from Omniab, Inc.